Harmonizing protocols across the health care system may bolster the feasibility of giving bispecifics to those with lymphoma in a community setting.
Joanna M. Rhodes, MD, MSCE
Advertisement
Articles by Joanna M. Rhodes, MD, MSCE
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA OKs Subcutaneous Amivantamab in EGFR+ NSCLC
2
Pelareorep Exhibits Activity in Second-Line KRAS-Mutated Metastatic CRC
3
Imlunestrant Combo Will Not Be Pursued for FDA Approval in Breast Cancer
4
SABCS 2025: The Top 5 Takeaways for Breast Cancer Research
5